Clinical outcomes of primary intraocular lymphoma patients treated with front-line systemic high-dose methotrexate and intravitreal methotrexate injection

WEI-LI MAHSIN-AN HOUHsu, Ya-JuiYa-JuiHsuYIN-KAI CHENJIH-LUH TANGWOEI TSAYPO-TING YEHCHUNG-MAY YANGCHANG-PING LINHWEI-FANG TIEN2021-01-042021-01-042016-03-010939-5555https://www.scopus.com/inward/record.uri?eid=2-s2.0-84959536001&doi=10.1007%2fs00277-015-2582-x&partnerID=40&md5=5a0ba0bd6128467efedf5e3fcd7753cehttps://scholars.lib.ntu.edu.tw/handle/123456789/537411Clinical outcomes of primary intraocular lymphoma patients treated with front-line systemic high-dose methotrexate and intravitreal methotrexate injectionjournal article10.1007/s00277-015-2582-x267328842-s2.0-84959536001